Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of aspirin and omeprazole before and after Roux-en-Y gastric bypass
NL-OMON39934Active, not recruiting
- Sponsor
- Haaglanden Medical Centre
- Start
- Aug 2013
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of aspirin and omeprazole in class III obesity, sponsored by Haaglanden Medical Centre. Primary endpoints: Blood concentrations of salicylic acid and omeprazole, Time to peak concentration (Tmax) and 3 more. Started Aug 2013; status: active, not recruiting.
02
Drugs
aspirinomeprazole
03
Conditions
class III obesity
Beyond the preview
Go deeper on NL-OMON39934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39934.